
Foundery Biosciences is an immunotherapy venture studio fund that accelerates early-stage R&D and builds drug discovery programs to cure diseases in autoimmunity, inflammation, and immuno-oncology. The company forms multiple thematically aligned startups to develop and commercialize immunotherapeutics, partnering with university collaborators to extend novel biological observations and generate advanced development candidates. Utilizing AI and deep immune phenotyping datasets, Foundery enhances understanding of immune states in health and disease to create transformative immunotherapies. Their capital-efficient model focuses on data-driven target validation and development, aiming for strong financial returns through biopharmaceutical partnerships. The company is led by experienced immunology experts and fosters a collaborative culture with academic and industry partners.

Foundery Biosciences is an immunotherapy venture studio fund that accelerates early-stage R&D and builds drug discovery programs to cure diseases in autoimmunity, inflammation, and immuno-oncology. The company forms multiple thematically aligned startups to develop and commercialize immunotherapeutics, partnering with university collaborators to extend novel biological observations and generate advanced development candidates. Utilizing AI and deep immune phenotyping datasets, Foundery enhances understanding of immune states in health and disease to create transformative immunotherapies. Their capital-efficient model focuses on data-driven target validation and development, aiming for strong financial returns through biopharmaceutical partnerships. The company is led by experienced immunology experts and fosters a collaborative culture with academic and industry partners.